Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

fuconojirimycin

Known as: fuco-nojirimycin 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

1-Deoxynojirimycin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis
Tumor hypoxia is a major mechanism of resistance to radiation therapy (RT), which is associated with poor prognosis in affected… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Development and characterization of sulfasalazine loaded fucosylated PPI dendrimer for the treatment of cytokine-induced liver damage.
The present investigation was aimed at exploring the targeting potential of sulfasalazine (NF-κB inhibitor drug) loaded fucose… Expand
2013
2013
Fucosylated Multiwalled Carbon Nanotubes for Kupffer Cells Targeting for the Treatment of Cytokine-Induced Liver Damage
ABSTRACTPurposeTo develop, characterize and exploring the sulfasalazine loaded fucoyslated multi walled carbon nanotubes for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2006
2006
Role of antithrombin and factor XIII in leukocyte-independent plasma extravasation during endotoxemia: an intravital-microscopic study in the rat.
BACKGROUND Platelet-endothelial interactions have been shown to be main mediators of leukocyte-independent endothelial damage… Expand
2006
2006
Discovery of different types of inhibition between the human and thermotoga maritima alpha-fucosidases by fuconojirimycin-based derivatives.
An efficient method for examining the selectivity of inhibitors on two alpha-fucosidases, one from Thermotoga maritima and the… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2004
2004
The organization of the fuc regulon specifying l-fucose dissimilation in Escherichia coli K12 as determined by gene cloning
SummaryIn Escherichia coli the six known genes specifying the utilization of l-fucose as carbon and energy source cluster at 60.2… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2004
2004
Discovery of picomolar slow tight-binding inhibitors of alpha-fucosidase.
Glycosidase inhibitors have shown great medicinal and pharmaceutical values as exemplified by the therapeutic treatment of… Expand
Highly Cited
2003
Highly Cited
2003
Rapid diversity-oriented synthesis in microtiter plates for in situ screening: discovery of potent and selective alpha-fucosidase inhibitors.
Polyhydroxypiperidines and pyrrolidines (also called iminocyclitols or aza-sugars) have attracted increasing attention because of… Expand
Highly Cited
2002
Highly Cited
2002
The Fine Structure of Caenorhabditis elegans N-Glycans* 210
We report the fine structure of a nearly contiguous series of N-glycans from the soil nematodeCaenorhabditis elegans. Five major… Expand
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Highly Cited
1990
Highly Cited
1990
Inhibition of alpha-L-fucosidase by derivatives of deoxyfuconojirimycin and deoxymannojirimycin.
Deoxyfuconojirimycin (1,5-dideoxy-1,5-imino-L-fucitol) is a potent, specific and competitive inhibitor (Ki 1 x 10(-8) M) of human… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE